 Infections patients intensive care units combination monobactam penicillin classic combination beta-lactam agent aminoglycoside open comparative study medical intensive care units efficacy combination aztreonam cloxacillin oxacillin cl combination tobramycin cephalosporin patients study evaluable patients severe pulmonary infections ventilatory support aztreonam combination rate clinical cure mortality Use aminoglycoside combination rate clinical cure mortality difference cure rate combinations significant Adverse effects negligible patients aztreonam combination superinfection patients aminoglycoside combination superinfection new renal insufficiency combination aztreonam cl oxacillin valuable alternative combination aminoglycoside cephalosporin